Celularity Inc (CELU)

Sector:
FINANCE
Industry:
GENERAL FINANCE
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Robert Joseph Hariri Gordon
Employees:
220
1325 AVENUE OF THE AMERICAS, 25TH FLOOR, NEW YORK, NY, 10019
2126163700

Celularity Inc. develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company was incorporated in 2016 and is headquartered in Florham Park, New Jersey.

Data derived from most recent annual or quarterly report
Market Cap 139.938 Million Shares Outstanding145.013 Million Avg 30-day Volume 798.654 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-2.52
Price to Revenue0.0 Debt to Equity0.396 EBITDA-196.942 Million
Price to Book Value9.0938 Operating Margin0.0 Enterprise Value825.627 Million
Current Ratio EPS Growth0 Quick Ratio
1 Yr BETA 1.2924 52-week High/Low 13.19 / 0.83 Profit Margin0.0
Operating Cash Flow Growth-103.6715 Altman Z-Score Free Cash Flow to Firm 0
Earnings Report2023-03-30
View SEC Filings from CELU instead.

View recent insider trading info

Celularity Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding CELU (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CELU

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2022-11-30 by HARIRI ROBERT J
  • 4: filed on 2022-11-29 by HARIRI ROBERT J
  • 4: filed on 2022-11-28 by HARIRI ROBERT J
  • 4: filed on 2022-10-04 by KILCOYNE ADRIAN
  • 3: filed on 2022-10-04 by KILCOYNE ADRIAN
  • 4: filed on 2022-08-30 by SCULLEY JOHN
  • 4: filed on 2022-08-18 by SMITH ROBIN L
  • 4: filed on 2022-07-15 by MAZUR MARC
  • 4: filed on 2022-07-15 by PARKS DIANE L.
  • 4: filed on 2022-07-15 by JONES ANNE

    • Events (8k)

  • 8-K: filed on 2022-12-16:
    Item 8.01: Other Events
  • 8-K: filed on 2022-11-10:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-10-06:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2022-09-23:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2022-09-15:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-09-08:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-07-20:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2022-07-14:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2022-06-17:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-06-03:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

    • Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    HARIRI ROBERT J CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    		 8,074,996 2022-11-30 5

    FLETCHER KYLE GENERAL COUNSEL

    • Officer
    		 34,170 2022-11-16 3

    KILCOYNE ADRIAN SEE REMARKS

    • Officer
    		 66,226 2022-10-03 2

    SCULLEY JOHN

    • Director
    		 804,739 2022-08-26 2

    SMITH ROBIN L

    • Director
    		 1,050,000 2022-08-16 2

    KEHLER DEAN C

    • Director
    		 90,297 2022-07-13 1

    MAZUR MARC

    • Director
    		 90,297 2022-07-13 1

    LIM KOK THAY

    • Director
    		 90,297 2022-07-13 1

    DIAMANDIS PETER

    • Director
    		 90,297 2022-07-13 1

    VON ESCHENBACH ANDREW C.

    • Director
    		 190,297 2022-07-13 1

    PARKS DIANE L.

    • Director
    		 90,297 2022-07-13 3

    GLOVER BRADLEY CHIEF TECHNOLOGY OFFICER

    • Officer
    • Director
    		 71,291 2022-07-13 2

    JONES ANNE CHIEF BUSINESS OFFICER

    • Officer
    		 61,558 2022-07-13 2

    HAINES JOHN R SEE REMARKS

    • Officer
    		 258,018 2022-04-13 1

    DUNN KEARY SEE REMARKS

    • Officer
    		 64,505 2022-04-13 1

    BEERS DAVID C CHIEF FINANCIAL OFFICER

    • Officer
    		 161,262 2022-04-13 1

    BRIGIDO STEPHEN PRES, FUNCTIONAL REGENERATION

    • Officer
    		 129,010 2022-04-13 1

    STARR INTERNATIONAL CO INC

    STARR INTERNATIONAL INVESTMENTS LTD.

    • 10% Owner
    		 15,281,389 2022-03-01 1

    PECORA ANDREW L PRESIDENT

    • Officer
    		 0 2021-09-15 0

    MIRAKHUR BELOO EVP, CLINICAL DEVELOPMENT

    • Officer
    		 125,000 2021-09-13 0

    BLOOM JAY R

    • Director
    		 56,053 2021-09-09 0

    SORRENTO THERAPEUTICS, INC.

    • 10% Owner
    		 20,422,124 2021-07-16 0

    STARR INTERNATIONAL CO INC

    • 10% Owner
    		 8,640,695 2021-07-16 1

    GX SPONSOR LLC

    • 10% Owner
    		 100,000 2021-07-16 0

    DRAGASAC LTD

    GENTING BERHAD

    • 10% Owner
    		 30,062,778 2021-07-16 0

    LEVY PAUL S

    • Director
    		 0 2019-05-20 0

    KELLETT ANDREA J. CHIEF FINANCIAL OFFICER

    • Officer
    		 0 2019-05-20 0

    MASELLI MICHAEL G VICE PRESIDENT OF ACQUISITIONS

    • Officer
    		 0 2019-05-20 0

    WEINBERGER HILLEL

    • Director
    		 0 2019-05-20 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    CELULARITY INC CELU 2023-02-06 15:15:03 UTC -9.2334 13.8034 500000
    CELULARITY INC CELU 2023-02-06 14:45:04 UTC -9.2619 13.8319 500000
    CELULARITY INC CELU 2023-02-06 14:15:04 UTC -9.2619 13.8319 500000
    CELULARITY INC CELU 2023-02-06 13:45:03 UTC -9.2619 13.8319 350000
    CELULARITY INC CELU 2023-02-06 13:15:03 UTC -9.2619 13.8319 300000
    CELULARITY INC CELU 2023-02-06 12:45:03 UTC -9.2619 13.8319 300000
    CELULARITY INC CELU 2023-02-03 22:15:03 UTC -9.2619 13.8319 200000
    CELULARITY INC CELU 2023-02-03 21:45:03 UTC -9.3864 13.9564 200000
    CELULARITY INC CELU 2023-02-03 21:15:03 UTC -9.3864 13.9564 200000
    CELULARITY INC CELU 2023-02-03 20:45:06 UTC -9.3864 13.9564 200000
    CELULARITY INC CELU 2023-02-03 20:15:04 UTC -9.3864 13.9564 200000
    CELULARITY INC CELU 2023-02-03 19:45:03 UTC -9.3864 13.9564 200000
    CELULARITY INC CELU 2023-02-03 19:15:04 UTC -9.3864 13.9564 200000
    CELULARITY INC CELU 2023-02-03 18:45:03 UTC -9.3864 13.9564 500000
    CELULARITY INC CELU 2023-02-03 18:15:03 UTC -9.3864 13.9564 500000
    CELULARITY INC CELU 2023-02-03 17:45:03 UTC -9.3864 13.9564 500000
    CELULARITY INC CELU 2023-02-03 17:15:04 UTC -9.3864 13.9564 500000
    CELULARITY INC CELU 2023-02-03 16:45:04 UTC -9.3864 13.9564 500000
    CELULARITY INC CELU 2023-02-03 16:15:03 UTC -9.3864 13.9564 500000
    CELULARITY INC CELU 2023-02-03 15:45:03 UTC -9.3864 13.9564 500000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments